Type 2 & other diabetes

Risk of progression to type 2 diabetes or regression to normoglycaemia among Ghanaians with prediabetes living in Ghana and the Netherlands: The RODAM prospective study

Diabet MedPublished Prospective cohort study

Main finding · Regression to normoglycaemiaResult — go to the resultIncident risk ratio 3.48 95% CI 2.39–5.05

Authors' conclusion

Among Ghanaians with prediabetes, regression to normoglycaemia was more frequent than progression to T2D, and more likely in non-migrants than in migrants.

Study context

Population
Ghanaians with prediabetes (WHO criteria) in the RODAM cohort, living in Ghana or Amsterdam; average follow-up 6.7 years
Participants
615 participants
Exposure
Non-migrants vs migrants
  • Non-migrantsn = 245
  • Migrantsn = 370reference
Outcome
Progression to T2D or regression to normoglycaemia
Follow-up
Average 6.7 years
Methodological detailsmultinational, adjusted for age, sex, follow-up duration, socioeconomic status, baseline BMI and FPG
  • Multinational
  • Adjusted for age, sex, follow-up duration, socioeconomic status, baseline BMI and FPG

Main finding

Regression to normoglycaemia · average follow-up 6.7 years

Incident risk ratio

3.48

95% CI 2.39–5.05

P < 0.001

By group

Non-migrantsvs Migrants
incident risk ratio 3.48 (95% CI 2.39–5.05); P < 0.001

As reported in the abstract

Observational data: associations, not effects.

Further findings

Progression to T2D · average follow-up 6.7 years · unadjusted proportions

P = 0.108

OutcomeIncident risk ratio (CI)P value
Progression to T2D · average follow-up 6.7 yearsFully adjusted1.20 (0.71–2.05)0.498

Overall cumulative incidence of T2D and of normoglycaemia

Cumulative incidence of T2D, overall
12.6%
Cumulative incidence of normoglycaemia, overall
28.9%

Original publication

Risk of progression to type 2 diabetes or regression to normoglycaemia among Ghanaians with prediabetes living in Ghana and the Netherlands: The RODAM prospective study. Diabet Med. Published 15 April 2026. doi:10.1111/dme.70332

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.